Month: December 2019

Rheos Medicines Announces Global Collaboration with Roche to Discover and Develop New Medicines in the Field of Immunometabolism

CAMBRIDGE, Mass .– (COMMERCIAL THREAD) – Rheos Medicines (Rheos), a biopharmaceutical company that harnesses knowledge in immunometabolism to create a new therapeutic class for patients with severe autoimmune disorders, inflammatory diseases and cancer, today announced that it has entered into a worldwide exclusive collaboration, option and license agreement with Roche to discover, develop and commercialize […]

Back To Top